Gan & Lee Pharmaceuticals.

SHSE:603087 Stock Report

Market Cap: CN¥27.7b

Gan & Lee Pharmaceuticals Dividends and Buybacks

Dividend criteria checks 2/6

Gan & Lee Pharmaceuticals is a dividend paying company with a current yield of 0.43% that is well covered by earnings.

Key information

0.4%

Dividend yield

-3.2%

Buyback Yield

Total Shareholder Yield-2.8%
Future Dividend Yield0.5%
Dividend Growth0.2%
Next dividend pay daten/a
Ex dividend daten/a
Dividend per shareCN¥0.200
Payout ratio20%

Recent dividend and buyback updates

Recent updates

Shareholders In Gan & Lee Pharmaceuticals (SHSE:603087) Should Look Beyond Earnings For The Full Story

Sep 04
Shareholders In Gan & Lee Pharmaceuticals (SHSE:603087) Should Look Beyond Earnings For The Full Story

Analysts Just Shipped A Sizeable Upgrade To Their Gan & Lee Pharmaceuticals. (SHSE:603087) Estimates

Apr 29
Analysts Just Shipped A Sizeable Upgrade To Their Gan & Lee Pharmaceuticals. (SHSE:603087) Estimates

Some Confidence Is Lacking In Gan & Lee Pharmaceuticals.'s (SHSE:603087) P/S

Mar 01
Some Confidence Is Lacking In Gan & Lee Pharmaceuticals.'s (SHSE:603087) P/S

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: 603087 has been paying a dividend for less than 10 years and during this time payments have been volatile.

Growing Dividend: 603087 has only been paying a dividend for 4 years, and since then payments have fallen.


Dividend Yield vs Market

Gan & Lee Pharmaceuticals Dividend Yield vs Market
How does 603087 dividend yield compare to the market?
SegmentDividend Yield
Company (603087)0.4%
Market Bottom 25% (CN)0.5%
Market Top 25% (CN)2.1%
Industry Average (Biotechs)1.2%
Analyst forecast (603087) (up to 3 years)0.5%

Notable Dividend: 603087's dividend (0.43%) isn’t notable compared to the bottom 25% of dividend payers in the CN market (0.55%).

High Dividend: 603087's dividend (0.43%) is low compared to the top 25% of dividend payers in the CN market (2.12%).


Earnings Payout to Shareholders

Earnings Coverage: With its low payout ratio (20.3%), 603087's dividend payments are well covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: At its current cash payout ratio (79.2%), 603087's dividend payments are covered by cash flows.


Discover strong dividend paying companies